Bupa profits drop by 70 per cent
By Liam McLaughlin - 09 March 11:13

The private health firm is hit hard by spending squeeze.

AFFiRiS to get MJFF grant for Parkinson's vaccine
By New Statesman - 17 December 11:03

Foundation will now support the development of the PD01 vaccine by AFFiRiS with $475,000

ACCC not to oppose Sigma acquisition of Aspen
By New Statesman - 16 December 11:02

ACCC was satisfied that the competition concerns in the relevant markets would be remedied through t

ISTA Pharma starts Phase 2 Bepotastine besilate nasal spray study
By New Statesman - 15 December 11:46

Study will investigate safety and efficacy of Bepotastine besilate in patients presenting with aller

Novartis signs merger agreement with Alcon
By New Statesman - 15 December 11:44

Under terms of agreement, merger consideration will include up to 2.8 Novartis shares and a CVA to b

Pharmasset commences dosing in PSI-7977 trial
By New Statesman - 15 December 11:40

Company anticipates to enroll approximately 40 patients infected with HCV genotype 2 or 3 who have n

Bayer HealthCare to build biologicals facility in Wuppertal, Germany
By New Statesman - 15 December 11:38

Main focus of Bayer HealthCare is on antibodies, coagulation factors and other therapeutic proteins

PAR, Experian enters into B2B data sharing partnership
By New Statesman - 13 December 10:33

EuroContactPool currently holds 23.5 million business records and 17.8 million named executives in 1

Jeffrey Kindler steps down as CEO of Pfizer
By New Statesman - 06 December 11:09

Kindler said in a statement that the "24/7 nature of my responsibilities" had been "extremely demand

Defense Intelligence Agency awards five-year SITE contract to CenTauri
By New Statesman - 01 December 10:55

Contract awarded by DIA to support information technology requirements

GSK to invest £500m and create 1000 jobs after UK tax changes
By New Statesman - 30 November 12:37

Pharmaceutical giant plans to reintroduce manufacturing plant to Britain after 25 years' absence.

USPTO issues patent for Mymetics virosome vaccines
By New Statesman - 30 November 11:09

Patent to allow Mymetics to develop a range of possible vaccines

Thomson Reuters purchases GeneGo
By New Statesman - 30 November 11:00

Acquisition enables Thomson Reuters to sell medical data to industry and academia

ADC Kerela files lawsuit against Cadila and Surya Pharma
By New Statesman - 29 November 12:36

Lawsuits were filed due to misbranding of Mokan and Micromox brands

BioSyent sees 14% rise in Q3 sales
By New Statesman - 25 November 11:15

Sales in first nine months of 2010 were $1,216,019

GSK and Dr Reddy's sign agreement for US oral penicillin facility
By New Statesman - 24 November 12:01

GSK will transfer ownership of its penicillin manufacturing site in Tennessee

MEDCAC panel reviews Dendreon Provenge impact
By New Statesman - 19 November 11:06

Review looks at treatment on health outcomes of patients with advanced prostate cancer.

Merck Gardasil gets support for approval from FDA advisory committee
By New Statesman - 18 November 14:50

Drug could prevent anal cancer in young people

Unilever to unveil 'Sustainable Living Plan'
By New Statesman - 15 November 12:40

Sustainable Living Plan to address greenhouse gas emissions, water use, and waste.

MedQuist sees 34 per cent increase in third quarter revenue
By New Statesman - 12 November 12:36

Net income rises to $8.97m.

Novartis halts clinical trial
By New Statesman - 12 November 12:27

Clinical trial program for investigational cancer treatment cancelled to reallocate funds to more pr

Federal prosecutors indict former GSK vice president with obstruction of probe
By New Statesman - 11 November 11:45

The company itself has not been charged with a crime

Kendle Q3 revenues fall
By New Statesman - 09 November 10:22

CEO Candace Kendle cites sequential improvement in net sales

Mannatech sees 23% fall in Q3 net sales
By New Statesman - 04 November 12:20

Co-CEO says Q3 recruiting levels are almost equal to those of Q2

Lilly to open diabetes research center in China
By New Statesman - 03 November 11:46

Research center established to meet growing unmet medical needs of Chinese diabetes sufferers

Parexel revenues surge in third quarter
By New Statesman - 02 November 11:05

Pharmaceutical services firm reports $342.26m revenues.

Global specialty enzymes market to reach $4.3bn by 2015
By New Statesman - 01 November 11:08

Europe and US are largest regional markets, while Asia-Pacific is poised to grow fastest.

GSK whistleblower gets $96m settlement
By New Statesman - 28 October 14:34

Cheryl Eckard to win largest payout to a whistleblower in US history.

Sangamo BioSciences third quarter revenues fall
By New Statesman - 28 October 12:29

Biotech firm posts $8.7m net loss.

Human Genome Sciences' revenues rise in third quarter
By New Statesman - 28 October 12:19

Firm reports over $50m revenues.

Pages